Mani Mohindru

Sr. VP, Corp. Strategy & IR, CURIS INC.

Companies

Cardiff Oncology, Inc.Chief executive officer Feb 18, 2026 to now¹
Cardiff Oncology, Inc.Board member Jun 14, 2021 to now²
CytomX Therapeutics, Inc.Board member Dec 18, 2020 to now³
Tvardi Therapeutics, Inc.Chief financial officer Aug 24, 2017 to Dec 4, 2019⁴
CURIS INCSr. VP, Corp. Strategy & IR Jan 25, 2016 to Feb 16, 2017⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cardiff Oncology, Inc. CRDF59,067 shares⁶$53.2K at $0.90Jul 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 14, 2026Bought 34,364 shares at $1.46 of Cardiff Oncology, Inc.⁶
Jun 18, 2026Bought 24,703 shares at $1.21 of Cardiff Oncology, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCardiff Oncology, Inc., Chief executive officer
2
SEC EDGARCardiff Oncology, Inc., Board member
3
SEC EDGARCytomX Therapeutics, Inc., Board member
4
SEC EDGARTvardi Therapeutics, Inc., Chief financial officer
5
SEC EDGARCURIS INC, Sr. VP, Corp. Strategy & IR
6
SEC EDGARCardiff Oncology, Inc. shares after the filing of Jul 14, 2026
7
SEC EDGARForm 4 filed Jun 22, 2026